Category: Cornea

Keratoconus, a progressive eye condition characterized by the thinning and bulging of the cornea, presents a significant challenge in the field of ophthalmology. For individuals afflicted with this disorder, the distorted shape of the cornea can lead to visual impairment and a diminished quality of life. While traditional treatments such as glasses, specialty contact lenses, […]

Corneal Tissue Addition Keratoplasty (CTAK) is a novel tissue addition technique that improves corneal curvature and vision for patients with keratoconus. Keratoconus is characterized by thinning of the cornea resulting in a steep cone shape and irregular astigmatism. In technical terms, CTAK is a form of lamellar keratoplasty where a customized sterilized corneal stromal inlay […]

What is a pterygium? A pterygium is a common eye condition characterized by the growth of a fleshy tissue on the conjunctiva, the clear tissue that covers the white part of the eye. This abnormal growth usually starts from the inner corner of the eye and gradually extends toward the cornea. Pterygium is often referred […]

Epi-off corneal collagen cross-linking (CXL) treatment treats progressive keratoconus and ectasia that develops after refractive surgery. The procedure received FDA approval in 2016. Dr. Greenstein and his colleagues conducted a study to determine how well the procedure faired over the years. The study concluded that the treatment appears to remain stable for the majority of […]

The Cornea and Laser Eye Institute is proud to sponsor the NJ Regional Horse Trials that were held on June 2, 2018! Julia Hersh, who is a very active participant is volunteering at this event.  We look forward to participating in more events in the future! Good luck everyone and more importantly, have fun! https://www.njregionponyclub.org/nj-regions-horse-trials—6-3-2018.html

Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.

Dr. Hersh was invited to lecture at the International Congress of Corneal Cross-Linking in Geneva, Switzerland on December 7-8, 2012. He has had the honor of lecturing at this event multiple times. He discussed U.S. Crosslinking Clinical Trials, Corneal Biomechanics in Crosslinking and Predictors of Success for Crosslinking. The Cornea and Laser Eye Institute has […]